Sign In

Kick-start your day in these highly interactive sessions focusing on a specialized area of liver disease or investigation. Take advantage of this opportunity to network with experts and your peers in a small group setting.

Note: Early Morning Workshops are limited to 50 participants in each workshop. A ticket is required.

Dates/Times

Saturday, November 10, 6:30 am - 7:30 am
Sunday, November 11, 6:30 am - 7:30 am
Monday, November 12, 6:30 am - 7:30 am

Continuing Medical Education

  • N/A

To view full programming being offered at The Liver Meeting®, visit the 2018 Online Program.

Saturday, November 10: Basic

  • EMW-01
    Inflammation in Portal Hypertension: Macrophages and Kupffer cells
    Frank Tacke, MD, PhD
    Jordi Gracia-Sancho, PhD
  • EMW-02
    Stem Cells in Liver Disease
    Laurie D. DeLeve, MD, PhD, FAASLD
    Robert E. Schwartz, MD, PhD
  • EMW-03
    CRISPR Therapy for Liver Diseases
    Karl-Dimiter Bissig, MD, PhD
    Clifford J. Steer, MD, FAASLD
  • EMW-04
    NASH: Basic Mechanisms and Targets
    Julia J. Wattacheril, MD, MPH
    Harmeet Malhi, MD, MBBS, FAASLD
  • EMW-05
    Ductular Reaction and Senescence: Chicken or the Egg?
    Mario Strazzabosco, MD, PhD, FAASLD
    James H. Tabibian, MD, PhD
  • EMW-06
    MicroRNA in Diagnosis and Treatment of Liver Disease
    Laura E. Nagy, PhD, FAASLD
    Emmanuel Thomas, MD, PhD

 

Saturday, November 10: Clinical

  • EMW-07
    Hepatitis C in Decompensated Cirrhosis: Treatment Before or After Liver Transplantation
    David E. Bernstein, MD, FAASLD
    Michael R. Charlton, MD, FRCP
  • EMW-08
    Assessing Frailty and Sarcopenia in Cirrhosis
    Elizabeth J. Carey, MD, FAASLD
    Jennifer C. Lai, MD
  • EMW-09
    ICU Management of Patients With Cirrhosis
    Constantine J. Karvellas, MD, SM, FRCPC
    Jody C. Olson, MD
  • EMW-10
    Management of Drug Interactions for Medications Commonly Prescribed in Chronic Liver Disease
    David Back, PhD
    Jennifer J. Kiser, PharmD
  • EMW-11
    Novel Treatments for Primary Biliary Cholestasis
    Olivier Barbier, PhD
    Cynthia Levy, MD, FAASLD
  • EMW-12
    Utilization of HCV+ Organs in HCV- Patients
    David S. Goldberg, MD, MSCE
    Paul Martin, MD, FAASLD
  • EMW-13
    Current and Future Treatments for Alcoholic Hepatitis
    Craig J. McClain, MD, FAASLD
    Mark R. Thursz, MD
  • EMW-14
    Mitigation of Long-Term Adverse Events in Liver Transplantation
    Michael P. Curry, MD, MRCP
    KV Narayanan Menon, MD, FAASLD
  • EMW-15
    Pathogenesis and Interventions in Pediatric NAFLD
    Stavra Xanthakos, MD
    Miriam B. Vos, MD, MSPH
  • EMW-16
    Mitochondrial Hepatopathies
    Alexander G. Miethke, MD
    James E. Squires, MD, MS

Sunday, November 11: Basic

  • EMW-17
    Microbiome and Liver Disease
    Tom H. Karlsen, MD, PhD
    Bernd Schnabl, MD
  • EMW-18
    Organelle Trafficking and Liver Disease
    Yasuko Iwakiri, PhD
    Carol A. Casey, PhD, FAASLD
  • EMW-19
    Inflammasome and Liver Disease
    Ariel E. Feldstein, MD
    Gyongyi Szabo, MD, PhD, FAASLD
  • EMW-20
    Mechanisms of Alcohol-Induced Liver Injury and Targets for New Therapies
    Gavin E. Arteel, PhD, FAASLD
    Ramon Bataller, MD, PhD
  • EMW-21
    Review of AASLD Hepatitis B Treatment Guidelines
    Marc G. Ghany, MD, FAASLD
    Maureen M. Jonas, MD, FAASLD
  • EMW-22
    Liver Fibrosis and Stellate Cell Biology
    Meena B. Bansal, MD, FAASLD
    Alan C. Mullen, MD, PhD

Sunday, November 11: Clinical

  • EMW-23
    Hepatitis C Controversies: Risks of Liver Cancer
    Massimo G. Colombo, MD
    Fasiha Kanwal, MD, MSHS
  • EMW-24
    Curative Therapy for Hepatitis B
    Tariq-Yacine Asselah, MD
    Robert G. Gish, MD, FAASLD
  • EMW-25
    Vascular Thrombosis and Managing Coagulation Disorders in Cirrhosis
    Patrick G. Northup, MD, MHES, FAASLD
    Alex Befeler, MD
  • EMW-26
    Systemic and Immunotherapies for Liver Cancer
    Laura M. Kulik, MD
    Roniel Cabrera, MD, MS
  • EMW-27
    New Insights in Pathogenesis and Management of PSC
    Cara L. Mack, MD, FAASLD
    Elizabeth J. Carey, MD, FAASLD
  • EMW-28
    Personalized Therapies for Pediatric Cholestatic Liver Diseases
    Saul J. Karpen, MD, PhD, FAASLD
    Richard J. Thompson, MD, PhD
  • EMW-29
    Non-Invasive Assessments of Liver Fibrosis
    Joseph K. Lim, MD, FAASLD
    Richard K. Sterling, MD, MSc, FAASLD
  • EMW-30
    Management of AKI in Patients With Cirrhosis
    Ayse L. Mindikoglu, MD, MPH
    Mitra K. Nadim, MD
  • EMW-31
    New Donor Allocation Polices: Too Much or Not Enough?
    Susan L. Orloff, MD, FACS, FAASLD
    Hugo E. Vargas, MD, FAASLD
  • EMW-32
    Controversies in Cannabis
    Amanda J. Chaney, DNP, ARNP, FNP-BC, FAANP
    Vicki Shah, PA
    Norah Terrault, MD, MPH, FAASLD

Monday, November 12: Basic

  • EMW-33
    Bile Acid Transporters in Liver Disease
    Benjamin L. Shneider, MD, FAASLD
    Michael H. Trauner, MD, FAASLD
  • EMW-34
    Exploring Mechanisms of HCC in NASH
    Ajay K. Duseja, MD, FACG, FSGEI, FAASLD
    Yujin Hoshida, MD, PhD
  • EMW-35
    New Therapeutic Targets for Hepatitis B
    Jordan J. Feld, MD, MPH, FAASLD
    Ulrike Protzer, PhD
  • EMW-36
    Modifying Liver Regeneration
    Lopa Mishra, MD, FAASLD
    Manuel Morales-Ruiz, PhD
  • EMW-37
    Mechanisms of Disease Resolution
    Natalia Nieto, PhD
    Steven A. Weinman, MD, PhD, FAASLD
  • EMW-38
    Immunologic and Genetic Factors in Pediatric Acute Liver Failure: Implications for Novel Therapies
    Estella M. Alonso, MD, FAASLD
    Mike A. Leonis, MD, PhD

 

Monday, November 12: Clinical

  • EMW-39
    New Models for Delivery of Care for Hepatitis C – ECHO or Beyond
    Sanjeev Arora, MD
    Andrew J. Muir, MD, FAASLD
  • EMW-40
    Management of the Adult Patient With a History of Pediatric Liver Disease
    Michael A. Heneghan, MD, MMedSc, FRCPI
    Kathleen M. Loomes, MD
  • EMW-41
    Assessment of Liver Transplant Candidates: When Is the Risk Too High?
    Michael L. Schilsky, MD, FAASLD
    Chirag Desai, MD
  • EMW-42
    Management Pearls in Acute Liver Failure
    Robert J. Fontana, MD, FAASLD
    Norman L. Sussman, MD, FAASLD
  • EMW-43
    New Approaches to Gastric Varices and Ectopic Variceal Hemorrhage
    Andres Cardenas, MD, MMSc, PhD, FAASLD
    Zachary H. Henry, MD
  • EMW-44
    Managing Acute and Chronic Liver Disease During Pregnancy
    Monika Sarkar, MD, MAS
    Grace L. Su, MD, FAASLD
  • EMW-45
    Mechanisms of Chronic Drug-Induced Liver Injury
    Naga P. Chalasani, MD, FAASLD
    Paul H. Hayashi, MD, MPH
  • EMW-46
    Current and Future Treatments for NASH
    Alina M. Allen, MD
    Rohit Loomba, MD
  • EMW-47
    Cardiopulmonary Complications of Cirrhosis
    Michael J. Krowka, MD
    Samuel S. Lee, MD, FAASLD
  • EMW-48
    Ethics in Academic Medicine: Real-Life Dilemmas
    Kenneth E. Sherman, MD, PhD, FAASLD
    Stephen D. Zucker, MD